Suboxone Lawsuit 2026: MDL 3092 Tooth Decay & Bellwether Update
Suboxone lawsuit claims allege that Suboxone buprenorphine/naloxone film can contribute to dental erosion, tooth decay and related dental damage when it dissolves in the mouth, and that adequate warnings were not provided during relevant periods. Federal cases are centralized in MDL 3092 in the Northern District of Ohio before Judge J. Philip Calabrese, and defendants dispute liability and individualized causation.
Choose the Suboxone Lawsuit Information You Need
Start with potential eligibility or current MDL status, then review dental injuries, evidence, settlement factors or the calculator.
What Is the Suboxone Tooth Decay Lawsuit About?
The current federal personal-injury litigation focuses on Suboxone buprenorphine/naloxone film and alleged dental erosion and decay. The Northern District of Ohio describes plaintiffs' common allegations as involving the film's alleged acidity, prolonged contact while dissolving in the mouth, dental injury and the adequacy of testing and warnings. These allegations remain disputed.
Suboxone Film
MDL 3092 specifically concerns Suboxone buprenorphine/naloxone film products-liability claims, not every form of buprenorphine treatment.
Dental Erosion & Decay
Plaintiffs allege tooth decay, erosion and other dental damage after use of film that dissolves in the mouth.
Liability Is Disputed
Individual cases can involve disputes over warnings, product use, dental baseline, causation, alternative causes, damages and filing deadlines.
Who May Qualify for a Suboxone Lawsuit?
There is no single public use-duration or procedure threshold that automatically determines legal eligibility. A claim-specific review generally considers use of Suboxone film, dental condition before and during treatment, injury timing, dental procedures, alternative causes, product records and applicable state law.
Suboxone Film Use
- Prescription, pharmacy or treatment-program records identifying Suboxone film.
- Approximate treatment dates, dose and duration.
- Use occurring before the claimed dental deterioration.
Documented Dental Injury
- New or worsening tooth decay or cavities.
- Dental erosion, fractured teeth or repeated restorative treatment.
- Infections, extractions, crowns, root canals, implants, bridges or dentures.
Dental Baseline & Causation
Prior dental records, hygiene history, tobacco use, dry mouth, diet, other medications and preexisting disease can matter when evaluating alternative causes and changes over time.
Damages & Deadlines
Treatment costs, future reconstruction, pain, functional limitations, lost income and state-specific filing rules may affect the legal and economic analysis.
Suboxone MDL 3092 Status and Bellwether Schedule
In re: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092, is centralized before Judge J. Philip Calabrese in the Northern District of Ohio. The August 3, 2026 JPML report lists 1,827 pending actions and 1,908 historical actions.
February 5, 2024 — MDL Centralized
JPML centralized federal Suboxone film dental-injury cases in the Northern District of Ohio.
March 27, 2026 — Bellwether Protocol Updated
The court entered Second Amended Case Management Order No. 15 with specific Core Discovery and Trial Pool dates.
July 13, 2026–January 15, 2027 — Core Depositions
The protocol schedules depositions for the 50 Core Discovery Pool cases during this period, subject to its stated holiday blackout.
July 16, 2026 — Provider Depositions
Case Management Order No. 23 governs provider depositions in Core Discovery Pool cases.
January 29, 2027 — Trial Pool
The protocol schedules a 15-case Trial Pool: five chosen by plaintiffs, five by defendants and five randomly selected.
March 2028 — Proposed First Trial Setting
Exhibit A lists March 2028 as a proposed first-trial setting, but the court states that this later schedule will be reduced to a future order.
What the FDA Says About Buprenorphine Dental Problems
In January 2022, FDA warned that dental problems had been reported with buprenorphine-containing medicines dissolved in the mouth. Reported problems included tooth decay, cavities, oral infections and tooth loss, including cases in people with no previous dental problems. FDA required a new dental-risk warning in prescribing information and Medication Guides.
Dental Cases Reviewed
FDA identified 305 reported dental cases, including 131 classified as serious.
Multiple Teeth Affected
FDA stated that 113 reports mentioned two or more affected teeth.
Extractions
Tooth extraction/removal was the most commonly reported treatment in the cases FDA summarized.
Median Time to Diagnosis
FDA reported a median time of approximately two years from starting treatment to diagnosis among the cases reviewed.
Tooth Decay, Erosion, Infection and Tooth Loss Claims
MDL 3092 centers on allegations of dental erosion and decay associated with Suboxone film. FDA's broader transmucosal-buprenorphine warning also describes cavities, infection, erosion and tooth loss among reported dental events.
Tooth Decay & Cavities
New or rapidly progressing caries may lead to fillings, crowns or more extensive treatment.
Dental Erosion & Fractures
Loss of enamel or structure may contribute to sensitivity, cracking or broken teeth.
Infection & Root Canals
Deep decay or infection can require endodontic treatment, antibiotics or extraction.
Tooth Loss & Reconstruction
Severe injury may involve extractions, implants, bridges, dentures or bone grafting.
Suboxone Film vs. Other Buprenorphine Medicines
The current federal MDL is specifically titled Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation. FDA's 2022 dental warning is broader and addresses buprenorphine-containing tablets and films dissolved under the tongue or against the inside of the cheek. FDA said it had not identified the same dental concern for routes such as patches and injections in that communication.
| Product / Route | FDA Dental Warning Context | MDL 3092 Context |
|---|---|---|
| Suboxone film | Buprenorphine/naloxone film dissolved in the mouth falls within FDA's transmucosal warning. | Central product at issue in MDL 3092. |
| Other buprenorphine films/tablets dissolved in mouth | FDA warning applies broadly to buprenorphine medicines dissolved in the mouth. | Do not assume every product is automatically part of MDL 3092; product-specific legal review is needed. |
| Patch / injection routes | FDA said it had not identified a dental-health concern related to these routes in its 2022 communication. | Not the central Suboxone film exposure described by the MDL court page. |
Evidence Commonly Reviewed in a Suboxone Dental Injury Claim
Prescription Proof
Pharmacy records, MAT clinic records, prescriber notes and insurance claims identifying Suboxone film and treatment dates.
Baseline Dental Records
Dental exams, X-rays and treatment history from before or early in treatment can help establish prior condition.
Injury & Procedure Records
Dental charts, X-rays, treatment plans, root canals, crowns, extraction notes, implants and dentures.
Damages Records
Paid bills, future treatment estimates, travel expenses, missed work and evidence of functional limitations.
Suboxone Lawsuit Settlement Status and Value Factors
There is no court-approved global Suboxone dental-injury settlement or verified average payout in MDL 3092. The litigation is still developing representative cases through bellwether discovery. Any TortAdvisor dollar ranges are educational planning models rather than official settlement amounts, offers or guarantees.
Number of Teeth Affected
Limited decay and widespread multi-tooth injury can create different treatment burdens.
Dental Procedures
Fillings, crowns, root canals, extractions, implants, dentures and reconstruction may affect damages.
Future Dental Care
Replacement restorations, implant maintenance and future treatment can matter when supported.
Baseline Dental Condition
Prior decay, periodontal disease and other conditions can affect causation and damages arguments.
Product & Timing Evidence
Reliable proof of Suboxone film use and a documented timeline can be important.
Legal Defenses & Deadlines
Warnings, causation, statutes of limitation and jurisdiction can affect value or viability.
How a Suboxone Dental Injury Claim May Be Evaluated
Confirm Film Use
Identify prescriptions, treatment dates, dose and pharmacy or program records.
Establish Dental Baseline
Gather earlier dental records and imaging where available.
Document Injury
Collect records showing decay, erosion, infection, fractures and procedures.
Review Causation
Evaluate timing, alternative causes, warnings and defendant-specific evidence.
Check Filing Rules
Review state statutes, discovery rules, venue and MDL requirements.
Document Damages
Preserve bills, future treatment plans, wage loss and other supported losses.
Suboxone Lawsuit Statute of Limitations
There is no single nationwide filing deadline for every Suboxone dental injury claim. Product-liability statutes of limitation and repose vary by state, and the start date can depend on dental diagnosis, discovery of a possible connection, prescription history, product use, warnings, residence and other facts.
Suboxone Lawsuit FAQ
How many Suboxone lawsuits are pending?
JPML's August 3, 2026 report lists 1,827 actions pending and 1,908 historical actions in MDL 3092.
What injuries are central to MDL 3092?
The Northern District of Ohio describes allegations that Suboxone film can cause dental erosion and decay and that dental warnings were inadequate.
Did FDA issue a Suboxone dental warning?
FDA issued a 2022 warning for buprenorphine medicines dissolved in the mouth, including combination products such as Suboxone, and required new dental-risk warnings.
Should someone stop taking Suboxone because of dental concerns?
No one should abruptly stop prescribed buprenorphine based on lawsuit information. FDA warns that sudden discontinuation can cause withdrawal and increase the risk of relapse, overdose and death.
Has there been a global Suboxone tooth decay settlement?
No court-approved universal Suboxone dental-injury settlement or payout matrix has been established in MDL 3092 as of this update.
What is happening with bellwether cases?
The current protocol places 50 Core Discovery Pool cases in depositions through January 15, 2027 and schedules selection of a 15-case Trial Pool on January 29, 2027.
What records can help a Suboxone dental claim?
Prescription records, pharmacy or treatment-program records, pre-treatment dental records, later dental charts and X-rays, procedure records, bills and future treatment plans can all be relevant.
Is every buprenorphine product part of MDL 3092?
No. MDL 3092 is specifically the Suboxone buprenorphine/naloxone film products-liability litigation. FDA's dental warning is broader and covers buprenorphine medicines dissolved in the mouth.
Suboxone Lawsuit Sources and Official References
- U.S. District Court for the Northern District of Ohio — MDL 3092. Official court page identifying the judge, litigation description and current orders.
- Judicial Panel on Multidistrict Litigation — Pending MDL Reports. August 3, 2026 report lists 1,827 pending and 1,908 historical actions in MDL 3092.
- Second Amended Case Management Order No. 15. March 27, 2026 bellwether protocol with Core Discovery and Trial Pool schedule.
- FDA — Dental problems with buprenorphine medicines dissolved in the mouth. January 12, 2022 Drug Safety Communication.
Request a Confidential Suboxone Dental Injury Case Review
If you used Suboxone film and later developed significant dental decay, erosion, tooth loss or related treatment needs, submit the prescription, dental injury and treatment information you know now for review.
